Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 2002

View Archived Issues

Abreva approved for OTC sale in Canada, Korea

Photofrin sNDA filed, orphan drug status granted, in high-grade dysplasia in Barrett's esophagus

Sankyo and Ube present antibacterial quinolizinones

New prenyltransferase inhibitors in early development at Merck

Fujisawa patents series for use in urinary incontinence

Novel calcilytic compounds and their use described in GSK patent

Aventis Pharma presents novel NHE3 inhibitors

VLA-4 antagonists with potential in asthma and inflammation

Antitumor xanthone compounds obtained from Streptomyces

Heat shock protein coinducer BRX-220 effective in rat model of acute pancreatitis

Effects of new SERM on bone, cholesterol and uterus compared to EE2 and levormeloxifene

Endogenous neuroprotective factor identified by Japanese group

Final analysis of phase III data for Zamyl in AML

Survival benefit for long-term atrasentan in HRPCa

Delay in PSA and clinical progression of prostate cancer achieved using Prostvac

KRX-211 has potential in septic shock

Neurontin receives FDA approval for postherpetic neuralgia

HIV immune responses induced by Remune plus CpG adjuvant in monkeys

Phase I study of aplidine as a three-hour infusion in solid tumor patients

Phase I/II enrollment completed for HuMax-IL-15 in rheumatoid arthritis

Endocyte licenses Galenica's GP-0100 for vitamin-based cancer treatments

Vion reprioritizes development program

Interim data announced from Neotrofin pilot study in Parkinson's disease

CPMP recommends approval of Visudyne in occult subfoveal CNV secondary to AMD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...